Gallstone disease is one of the most prevalent gastrointestinal diseases with a substantial burden to health care systems that is supposed to increase in ageing populations at risk. Aetiology and pathogenesis of cholesterol gallstones still are not well defined, and strategies for prevention and efficient nonsurgical therapies are missing. This review summarizes current concepts on the pathogenesis of cholesterol gallstones with focus on the uptake and secretion of biliary lipids and special emphasis on recent studies into the genetic background.Keywords: gastroenterology, hepatology.Gallstones are a common clinical finding in the Western populations. Ultrasound studies indicate mean prevalence rates of 10-15% in adult European, and of 3-5% in African and Asian populations [1]. In the US, the prevalence rates range from 5% for nonHispanic black men to 27% for Mexican-American women [2]. In American Indians, gallstone disease is epidemic and found in 73% of adult female Pima Indians [3], and in 30% of male and 64% of female in other American Indians [4].More than 80% of gallstone carriers are unaware of their gallbladder disease [5,6], but about 1-2% per year of patients develop complications and need surgery [7]. In the US, gallstone disease has the most common inpatient diagnosis among gastrointestinal and liver diseases [8] and stands for $5.8 billion direct costs, exceeded only by gastroesophageal reflux disease [9].
Risk factorsFemale gender, fecundity, and a family history for gallstone disease are strongly associated with the formation of cholesterol gallstones [10] (Table 1). Obesity [11,12] as well also other factors contributing to the metabolic syndrome [13] such as dyslipidemia (in particular hyperlipoproteinemia type IV [14-16] with hypertriglyceridemia and low HDL cholesterol), hyperinsulinemia-insulinresistence [17,18] or overt type 2 diabetes are risk factors for the development of gallstones, itself supposed to be a complication of the metabolic syndrome [19]. Oestrogen-treatment enhances the risk, both in women when used for anticonception or hormone-replacement [20] and in men with prostatic cancer [21,22]. Among specific dietary factors, short-time high cholesterol [23] as well as high-carbohydrate diets were associated with increased risk for gallstones [24,25], and in highly prevalent areas, the intake of legume [26], while unsaturated fats [27], coffee [28], and moderate consumption of alcohol [24,29] seem to reduce the risk. Also physical activity was found to decrease the risk for symptomatic gallstone disease, both for men and women [30,31], and independent of weight reduction. On the other hand, rapid active weight loss [32,33] and weight cycling [34,35] strongly increase the risk for the development of gallstones. Thus, weight reductions should not exceed 1.5 kg per week [36]. Fibrates, used for the treatment of dyslipidemia, interfere with cholesterol and bile acid synthesis and increase cholesterol secretion into bile [37,38]. However, in contrast to the prototype Clofibrate, during ...